Form 4: Blueprint Medicines CFO Exercises Stock Options
SEC Form 4 Filing
Michael Landsittel, CFO of Blueprint Medicines, exercised stock options on May 8, 2024, acquiring shares at prices of $1.87 and $8.8.
Summary
- Michael Landsittel, the Chief Financial Officer of Blueprint Medicines Corp, executed transactions involving the company's common stock on May 8, 2024.
- Landsittel exercised stock options to acquire 26,363 shares at $1.87 and 1,818 shares at $8.8.
- Following these transactions, Landsittel directly owns 75,467 shares of Blueprint Medicines Corp.
- The exercised options were granted on February 10, 2015, and October 8, 2014, and were fully vested as of the transaction date.
- A Limited Power of Attorney was executed on January 31, 2023, granting certain individuals the authority to act on behalf of Michael Landsittel in matters related to Section 13 and Section 16 of the Securities Exchange Act of 1934.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing, so the sentiment is neutral.
Positives
- The CFO's decision to exercise options could be interpreted as a sign of confidence in the company's future prospects.
Industry Context
Insider transactions are closely monitored as they can provide insights into a company's performance and management's confidence.
Stakeholder Impact
- Shareholders may view the CFO's stock option exercise as a positive signal.
Key Dates
| Date | Description |
|---|---|
| 2014-10-08 | Grant date of some of the stock options exercised. |
| 2015-02-10 | Grant date of some of the stock options exercised. |
| 2023-01-31 | Date of Limited Power of Attorney execution. |
| 2024-05-08 | Date of stock option exercise. |
| 2024-05-09 | Date of Form 4 signature. |
| 2024-10-08 | Expiration date of some of the stock options exercised. |
| 2025-02-10 | Expiration date of some of the stock options exercised. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.